[Oncogenic hypophosphatemic osteomalacia].
In the courses of six years a severe hypophosphataemic osteomalacia, painful motor impairment and multiple rib fractures developed in a 51-year-old man. The symptoms gradually improved within one year under treatment with 3 micrograms daily of 1,25-dihydroxycholecalciferol, 3 g phosphorus and 3 g calcium, and biochemical parameters and the bone scintigram became normal. Ultimately, computed tomography, scintigraphy and digital subtraction angiography revealed a highly vascularized tumour in the condylar aspect of the right femur, and it was chiselled out. Histologically it was a mesenchymal phosphaturic tumour of haemangiopericytoma type of questionable benignity. After the operation the patient was symptom-free for some weeks without any drug treatment, but the latter was then resumed because of renewed bone pain. By now, two years later, he is essentially without pain and has full mobility. However, repeat scintigraphy and angiography revealed renewed tumour growth in the right femoral condyle.
Schultze
G
G
Abteilung Nephrologie, Humboldt-Krankenhauses, Berlin.
Delling
G
G
Faensen
M
M
Haubold
R
R
Loy
V
V
Molzahn
M
M
Pommer
W
W
Semler
J
J
Trempenau
B
B
D002117:Calcitriol / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D005266:Femoral Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000601:surgery; D006393:Hemangiopericytoma / Q000150:complications* / Q000175:diagnosis / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000188:drug therapy / Q000209:etiology*; D010710:Phosphates / Q000097:blood*; D010758:Phosphorus / Q000627:therapeutic use
D010710:Phosphates; D010758:Phosphorus; D002117:Calcitriol; D002118:Calcium
Onkogene hypophosphatätmische Osteomalazie.